GL1X · GenesisL1 explorer

MolNFT v2 · #214793 · protein

SLC15A4 inhibitor complex

8JZX · lysosomal transporter,ALFA tag,lysosomal transporter: “SLC15A4 inhibitor complex”. Electron microscopy at 2.5, 3 ligands (CLR, Q09, NAG), 10 pockets (best druggability 0.81). MolNFT v2 #214793 on GenesisL1: 3D structure, binding…

PDB
8JZX
Type
protein
Length
910 residues
Chains
2
Method
electron microscopy
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
2.5
Source
Homo sapiens; synthetic construct
Molecule
lysosomal transporter,ALFA tag,lysosomal transporter
UniProt
Q8N697
Ligands
CLR, Q09, NAG
Pockets
10 · best druggability 0.81

Structure

electron microscopy · resolution 2.5 · 1 distinct chain · 73% helix, 3% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, Blysosomal transporter,ALFA tag,lysosomal transporterprotein45573% helix, 3% strandQ8N697

Ligands and binding sites

  • CLR · Cholesterol · ligand · 4 copies · chains A, B
  • Q09 · 2-(4-ethoxyphenyl)-N-[3-[(2R)-2-methylpiperidin-1-yl]propyl]quinoline-4-carboxamide · ligand · 2 copies · chains A, B
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

10 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111110.810.8273Q09
210800.800.8171Q09
37160.740.7844CLR
46630.680.7663CLR
5860.360.7621empty

Interfaces

1 interface between chains.

  • A–B · 719 Ų buried · 0 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 2 disulfide, 2 glycan (disulfide, N-glycosylation).

Compared structures

  • Q8N697 · AlphaFold monomer V2.0 prediction for solute carrier family 15 member 4 (Q8N697) · a predicted model of the same protein · chain A against A, TM-score 0.74

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.